-
-
L287004-10mgProduct Describtion:L-168049 is a potent, selective, orally active and non-competitive Glukagon receptor antagonist with IC50s of 3.7 nM, 63 nM, and 60 nM for human, murine, and canine Glukagon receptors, respectively.
-
L287004-25mgProduct Describtion:L-168049 is a potent, selective, orally active and non-competitive Glukagon receptor antagonist with IC50s of 3.7 nM, 63 nM, and 60 nM for human, murine, and canine Glukagon receptors, respectively.
-
L287004-50mgProduct Describtion:L-168049 is a potent, selective, orally active and non-competitive Glukagon receptor antagonist with IC50s of 3.7 nM, 63 nM, and 60 nM for human, murine, and canine Glukagon receptors, respectively.
-
L287004-5mgProduct Describtion:L-168049 is a potent, selective, orally active and non-competitive Glukagon receptor antagonist with IC50s of 3.7 nM, 63 nM, and 60 nM for human, murine, and canine Glukagon receptors, respectively.
-
L287661-10mgSelective CCK2antagonist.
-
L287661-5mgSelective CCK2antagonist.
-
-
-
-
-